HBEAG LOSS INCIDENCE RATE DECLINED SHARPLY AFTER FIRST YEAR IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUE THERAPY

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalHepatology
Volume70
StatePublished - 2019

Cite this